November 25, 2018
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
February 8, 2018
Since the news about the lawsuits starting in 2016, Insys share price has dropped 65.56 percent from $28.63 to $9.62,...
December 25, 2017
The Investing News Network takes a look at what could be the landscape for the pharma industry and its investors...
April 3, 2017
More than 81,000 Mylan EpiPen devices have been recalled by the company resulting from a failure to activate auto-injection.
March 7, 2017
President Donald Trump's tweet send pharma stocks down after promising he would bring drug prices down.
March 2, 2017
Drugs with low oral bioavailability risk failure in clinical trial: minimal absorption, after all, can translate to reduced efficacy. As...
January 16, 2017
These three blockbuster drugs transformed pharmaceutical investing. But will we ever see anything like them again?